<DOC>
	<DOCNO>NCT00987064</DOCNO>
	<brief_summary>The purpose study determine whether clean air administer breathe zone Temperature control Laminar Airflow ( TLA ) night effective treatment perennial allergic asthma .</brief_summary>
	<brief_title>Clinical Effects Temperature Controlled Laminar Airflow ( TLA )</brief_title>
	<detailed_description>Background : Exposure inhale allergen pathogenetic factor allergic asthma . However , study previously look air clean device show little effect patient perennial allergic asthma . Aims objectives : This study aim investigate novel treatment , TLA , use temperature control laminar airflow low particle concentration direct breathe zone teenager adults allergic asthma night sleep . The hypothesis decrease allergen exposure night effect bronchial inflammation quality life . Method : Patients randomized start active placebo treatment 10 week . All patient receive active placebo treatment unfiltered air , 2-week wash-out period treatment . Maintenance treatment inhale corticosteroid unaltered trial period . Health related quality life ( miniAQLQ ) primary effectiveness measure . Exhaled nitric oxide ( FeNO ) spirometry also investigate .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Diagnosed asthma 1 year . More 12 % reactivity FEV1 bronchodilating medication le 90 % FEV1 reference value accord Hedenström . Perennial allergy At least 3mm wheal reaction skin prick test least one follow : House dust , Mold spores , dust mite , animal hair dander . Little reactivity inhalant allergen . No known allergy another inhalant allergen chemical exposure winter time . No allergen injection treatment precede 2 year . A history requirement daily medication asthma include ; 400µg steroid medication ( Pulmicort equal ) child 800µg adult . Beta agonist treatment le 4 day per week . Willingness follow clinical trial protocol , include medication , baseline followup visit procedure . Inclusion another Allergen avoidance program . Smoking family Participation drug trial</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Protexo</keyword>
	<keyword>Asthma</keyword>
	<keyword>Temperature control Laminar Airflow</keyword>
	<keyword>Perennial allergy</keyword>
	<keyword>Quality life</keyword>
	<keyword>MiniAQLQ</keyword>
	<keyword>FeNO</keyword>
	<keyword>FEV1</keyword>
	<keyword>PEF</keyword>
</DOC>